Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia

Archive ouverte

Bertocchio, Jean-Philippe | Tafflet, Muriel | Koumakis, Eugénie | Maruani, Gérard | Vargas-Poussou, Rosa | Silve, Caroline | Nissen, Peter | Baron, Stéphanie | Prot-Bertoye, Caroline | Courbebaisse, Marie | Souberbielle, Jean-Claude | Rejnmark, Lars | Cormier, Catherine | Houillier, Pascal

Edité par CCSD ; Endocrine Society -

International audience. Abstract Context Parathyroid-related hypercalcemia is due to primary hyperparathyroidism (PHPT) or to familial hypocalciuric hypercalcemia (FHH). PHPT can lead to complications that necessitate parathyroidectomy. FHH is a rare genetic disease resembling PHPT; surgery is ineffective. A reliable method for distinguishing FHH from PHPT is needed. Objective To develop an easy-to-use tool to predict if a patient has PHPT. Design Retrospective analysis of two prospective cohorts. Development of an unsupervised risk equation (Pro-FHH). Setting University hospitals in Paris, France, and Aarhus, Denmark. Participants Patients (Paris: 65 with FHH, 85 with PHPT; Aarhus: 38 with FHH, 55 with PHPT) were adults with hypercalcemia and PTH concentration within normal range. Main Outcome Measures Performance of Pro-FHH to predict PHPT. Results Pro-FHH takes into account plasma calcium, PTH, and serum osteocalcin concentrations, and calcium-to-creatinine clearance ratio calculated from 24-hour urine collection (24h-CCCR). In the Paris cohort, area under the receiver operating characteristic curve (AUROC) of Pro-FHH was 0.961, higher than that of 24h-CCCR. With a cutoff value of 0.928, Pro-FHH had 100% specificity and 100% positive predictive value for the diagnosis of PHPT; it correctly categorized 51 of 85 patients with PHPT; the remaining 34 were recommended to undergo genetic testing. No patients with FHH were wrongly categorized. In an independent cohort from Aarhus, AUROC of Pro-FHH was 0.951, higher than that of 24h-CCCR. Conclusion Pro-FHH effectively predicted whether a patient has PHPT. A prospective trial is necessary to assess its usefulness in a larger population and in patients with elevated PTH concentration.

Consulter en ligne

Suggestions

Du même auteur

Signification of distal urinary acidification defects in hypocitraturic patients

Archive ouverte | Forni Ogna, Valentina | CCSD

International audience

Tubular Acidification Defect in Adults with Sickle Cell Disease

Archive ouverte | Cazenave, Maud | CCSD

International audience. Background and objectives: Metabolic acidosis is a frequent manifestation of sickle cell disease but the mechanisms and determinants of this disorder are unknown. Our aim was to characterize ...

Fibroblast growth factor 23 but not copeptin is independently associated with kidney failure and mortality in patients with chronic kidney disease

Archive ouverte | Michon-Colin, Arthur | CCSD

International audience. ABSTRACT Background Copeptin and intact fibroblast growth factor 23 (iFGF23) increase early during chronic kidney disease (CKD) and may be predictive of unfavourable outcomes. The aim of this...

Chargement des enrichissements...